|
1719
|
D 106669
|
Potent and selective PI3K inhibitor |
€85.00 |
|
2494
|
D-Luciferin
|
Natural substrate of firefly luciferase. Compound for bioluminescence imaging (BLI) |
€95.00 |
|
2895
|
D3-βArr
|
Positive allosteric modulator (PAM) of TSH receptor |
€105.00 |
|
3117
|
Dabigatran etexilate
|
Prodrug of Dabigatran; Thrombin inhibitor |
€70.00 |
|
3459
|
Dacarbazine
|
DNA alkylating agent; antineoplastic agent |
€50.00 |
|
2093
|
Daclatasvir dihydrochloride
|
Hepatitis C virus (HCV) NS5A protein inhibitor |
€70.00 |
|
3235
|
Dacomitinib
|
Potent irreversible pan-HER inhibitor |
€60.00 |
|
1918
|
Daglutril
|
Orally active, dual ECE/NEP inhibitor |
€125.00 |
|
1962
|
Dalcetrapib
|
Inhibitor of cholesterylester transfer protein (CETP) |
€135.00 |
|
1669
|
Danoprevir
|
HCV NS3/4A serine protease inhibitor |
€90.00 |
|
2257
|
Dansyl-PEG-phenylboronic acid
|
Dansylamide functionalized PEG-phenylboronic acid; Protein labeling reagent |
€120.00 |
|
3121
|
Dapagliflozin
|
Potent and selective hSGLT2 inhibitor |
€60.00 |
|
3475
|
Dapansutrile
|
Selective and orally active NLRP3 inflammasome inhibitor |
€70.00 |
|
1534
|
Dapivirine
|
NNRT inhibitor |
€80.00 |
|
1484
|
DAPT
|
γ-Secretase inhibitor |
€90.00 |
|
3968
|
Darapladib
|
Selective lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor |
Inquire |
|
3137
|
Darunavir
|
HIV-1 protease inhibitor |
€60.00 |
|
1392
|
Dasatinib
|
Bcr-Abl and Src tyrosine kinase inhibitor |
€90.00 |
|
1826
|
DBeQ
|
Inhibitor of p97 ATPase |
€90.00 |
|
3922
|
dBET1
|
BET bromodomain degrader |
Inquire |
|
3097
|
DBPR211
|
Potent and selective peripherally restricted CB1 antagonist/inverse agonist |
€125.00 |
|
1166
|
DC 838
|
CypA inhibitor |
€135.00 |
|
3057
|
DC260126
|
GPR40 receptor antagonist (FFA1) |
€65.00 |
|
2123
|
DCC 2036
|
An orally active Bcr-ABL inhibitor |
€125.00 |
|
3292
|
dCeMM1
|
Glue degrader of RBM39 |
€110.00 |
|
3293
|
dCeMM2
|
Glue degrader of Cyclin K |
€100.00 |
|
3200
|
DCLK1-IN-1
|
Potent, selective and orally bioavailable DCLK1/2 inhibitor |
€140.00 |
|
3216
|
DCZ0415
|
AAA-ATPase TRIP13 inhibitor |
€85.00 |
|
3518
|
DCZ0805
|
NF-κB activation inhibitor |
€130.00 |
|
3264
|
DDO-6600
|
Targeted covalent inhibitor of Hsp90 |
€120.00 |